Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
Nanoparticles have become a powerful tool in oncology not only as carrier of the highly toxic chemotherapeutic drugs but also as imaging contrast agents that provide valuable information about the state of the disease and its progression. The enhanced permeation and retention effect for loaded nanoc...
Main Authors: | Alejandro Baeza, Maria Vallet-Regí |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/10/957 |
Similar Items
-
Characterization of a Mesoporous Silica Nanoparticle Formulation Loaded with Mitomycin C Lipidic Prodrug (MLP) and In Vitro Comparison with a Clinical-Stage Liposomal Formulation of MLP
by: Miguel Manzano, et al.
Published: (2022-07-01) -
Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
by: Yashaswi Dutta Gupta, et al.
Published: (2024-01-01) -
Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect
by: Alex N. Frickenstein, et al.
Published: (2021-04-01) -
Theranostic Mesoporous Silica Nanoparticles Loaded With a Curcumin-Naphthoquinone Conjugate for Potential Cancer Intervention
by: Lara G. Freidus, et al.
Published: (2021-05-01) -
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
by: Juan L. Paris, et al.
Published: (2020-06-01)